Zdenka Hruskova
Overview
Explore the profile of Zdenka Hruskova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wester Trejo M, Sadeghi M, Singh S, Mahmoodian N, Sharifli S, Hruskova Z, et al.
Kidney Int Rep
. 2025 Feb;
10(2):457-465.
PMID: 39990883
Introduction: The histopathological classification for antineutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis (ANCA-GN) is a well-established tool to reflect the variety of patterns and severity of lesions that can occur in kidney...
2.
Buryskova Salajova K, Malik J, Kaiserova L, Hladinova Z, Hruskova Z, Janakova S, et al.
Ren Fail
. 2025 Feb;
47(1):2466822.
PMID: 39988812
Objectives: This cross-sectional analysis from the CZecking Heart Failure in patients with advanced Chronic Kidney Disease trial (ISRCTN18275480) examined pulmonary hypertension and right ventricular-pulmonary arterial coupling in patients on chronic...
3.
Tesar V, Hartinger J, Hruskova Z
Expert Rev Clin Pharmacol
. 2024 Nov;
17(12):1099-1113.
PMID: 39611585
Introduction: ANCA-associated vasculitis (AAV) is a rare, life-threatening disease which may result in serious pulmonary and kidney damage. Cyclophosphamide or rituximab and high-dose glucocorticoids significantly improved patient outcomes, but at...
4.
Hruskova Z, Tesar V
Cesk Patol
. 2024 Nov;
60(3):150-154.
PMID: 39580233
ANCA-associated vasculitides (AAV) are small-vessel necrotizing vasculitides, with no or few immune deposits. They are usually associated with the presence of ANCA antibodies (AntiNeutrophil Cytoplasmic Antibody), targeted either against proteinase...
5.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana L, Diaz M, et al.
J Am Soc Nephrol
. 2024 Oct;
PMID: 39431468
No abstract available.
6.
Gisslander K, White A, Aslett L, Hruskova Z, Lamprecht P, Musial J, et al.
Lancet Rheumatol
. 2024 Aug;
6(11):e762-e770.
PMID: 39182506
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a heterogenous autoimmune disease. While traditionally stratified into two conditions, granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), the subclassification of ANCA-associated vasculitis...
7.
Scott J, White A, Walsh C, Aslett L, Rutherford M, Ng J, et al.
RMD Open
. 2024 Apr;
10(2).
PMID: 38688690
Objective: ANCA-associated vasculitis (AAV) is a relapsing-remitting disease, resulting in incremental tissue injury. The gold-standard relapse definition (Birmingham Vasculitis Activity Score, BVAS>0) is often missing or inaccurate in registry settings,...
8.
Hartinger J, Sima M, Hruskova Z, Pilkova A, Kratky V, Rysava R, et al.
Biomed Pharmacother
. 2024 Apr;
175:116655.
PMID: 38678967
Objectives: Rituximab is being increasingly prescribed for the treatment of autoimmune glomerular diseases. While it is highly effective for some diseases, the response is less predictable for others, which may...
9.
Alparslan C, Malyszko J, Caskey F, Aleckovic-Halilovic M, Hruskova Z, Arruebo S, et al.
Kidney Int Suppl (2011)
. 2024 Apr;
13(1):29-42.
PMID: 38618499
Delivery of care for kidney failure (KF) globally has a significant disparity; even in some countries, it means end of life for the person. The International Society of Nephrology Global...
10.
Kratky V, Valerianova A, Hruskova Z, Tesar V, Malik J
Curr Atheroscler Rep
. 2024 Jan;
26(4):103-109.
PMID: 38289577
Purpose Of Review: Chronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular disease (CVD). This review summarizes known risk factors, pathophysiological mechanisms, and current therapeutic possibilities,...